Trial record 1 of 1 for:
KN-8701
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04913285 |
|
Recruitment Status :
Recruiting
First Posted : June 4, 2021
Last Update Posted : March 12, 2024
|
Sponsor:
Kinnate Biopharma
Information provided by (Responsible Party):
Kinnate Biopharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2024 |
| Estimated Study Completion Date : | June 2024 |